Raymond James Financial’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.7K Sell
10,419
-87,412
-89% -$350K ﹤0.01% 5198
2025
Q1
$89K Buy
97,831
+23,666
+32% +$21.5K ﹤0.01% 4510
2024
Q4
$205K Buy
+74,165
New +$205K ﹤0.01% 4365